Home > Focus Areas > HIV Connect > Post
Pharmacogenetics of dolutegravir plasma exposure among Southern Africans living with HIV
Source : https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac174/6580078?login=false
AbstractBackground. Dolutegravir is a component of preferred antiretroviral therapy (ART) regimens. We characterised the pharmacogenetics of dolutegravir exposu
Conclusions: In South Africa, rs887829 and rs28899168 in the UGT1A locus were independently associated with dolutegravir AUCVAR. The novel rs28899168 association warrants replication. This study enhances understanding of dolutegravir pharmacogenetics in Africa.